RPL23A and neoplasm: Patient samples harboring RPL23A amplification displayed 1.5 fold higher average RPL23A mRNA expression levels compared to RPL23A diploid tumor samples (Wilcoxon test, W = 3316, p = 0.003) (Supplementary Figure 3A).